Stockscreener 앱 받기
79.07
1.17%
-0.94
시간 외 거래:
80.97
1.90
+2.40%
전일 마감가:
$80.01
열려 있는:
$83.8
하루 거래량:
67,711
Relative Volume:
2.48
시가총액:
$220.27M
수익:
$18.97M
순이익/손실:
$-8.99M
주가수익비율:
-24.51
EPS:
-3.2257
순현금흐름:
$-33.87M
1주 성능:
+4.95%
1개월 성능:
-12.26%
6개월 성능:
+182.49%
1년 성능:
+1,314%
1일 변동 폭
$75.00
$83.80
1주일 범위
$61.92
$93.53
52주 변동 폭
$4.018
$97.97
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Compare SLGL vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
79.07 | 222.89M | 18.97M | -8.99M | -33.87M | -3.2257 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-19 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2019-12-31 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-31 | 재확인 | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd 주식(SLGL)의 최신 뉴스
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610 - TipRanks
Sol-Gel (NASDAQ: SLGL) prices $33.1M oversubscribed share offering - Stock Titan
Sol‑Gel (NASDAQ: SLGL) raises ~$30.8M via 459,112‑share offering to fund SGT‑610 - Stock Titan
Opaleye Management (SLGL) linked entities buy 39,665 Sol-Gel shares - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Sol-Gel Technologies (SLGL) Prices Oversubscribed Offering, Shar - GuruFocus
SLGL Announces Offering with TD Cowen and LifeSci Capital as Managers - GuruFocus
[EFFECT] Sol-Gel Technologies... | SLGL SEC FilingForm EFFECT - Stock Titan
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - weeklyvoice.com
Sol-Gel brings in $33.1M to fund SGT-610 development - Stock Titan
Sol-Gel Technologies Ltd. announces pricing of oversubscribed underwritten offering - marketscreener.com
Sol-Gel Technologies Ltd. Announces Pricing of $33.1 Million Underwritten Offering of Ordinary Shares - Quiver Quantitative
Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering - TradingView
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - GlobeNewswire Inc.
Opaleye (SLGL) affiliate discloses 460,335 shares, 16.52% stake - Stock Titan
Sol-Gel Technologies Ltd. (SLGL) reports Q4 loss, misses revenue estimates - MSN
If You Invested $1,000 in Sol Gel Tech (SLGL) - Stock Titan
Market Fear: Why is Sol Gel Technologies Ltd stock going upWeekly Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Sol-Gel Technologies (NASDAQ:SLGL) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Form 144 Sol-Gel Technologies Ltd. For: 12 March By Investing.com - Investing.com Australia
Sol Gel Technologies Ltd expected to post a loss of $1.84 a shareEarnings Preview - TradingView
Retail Trends: Can Sol Gel Technologies Ltd maintain its current growth rate2026 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
Sol Gel Technologies (SLGL) Quarterly Profit Swing Challenges Bullish Turnaround Narratives - simplywall.st
Sol‑Gel (NASDAQ: SLGL) registers resale of 656,000 ordinary shares via Form F-3 - Stock Titan
Sol-Gel Technologies Ltd. (SLGL) Announces Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance Singapore
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 - The Manila Times
Sol-Gel Technologies, Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Quiver Quantitative
Sol-Gel Technologies (NASDAQ: SLGL) flags losses and going concern risk in 20-F - Stock Titan
SLGL: 2025 revenue grew to $19.4M, net loss narrowed, and SGT-610 Phase 3 trial reached full enrollment - TradingView
Sol-Gel posts audited 2025 financial statements in SEC filing - Stock Titan
Should I buy SolGel Technologies (SLGL) - Zacks Investment Research
Sol-Gel Technologies (SLGL) COO discloses stock option positions in Form 3 - Stock Titan
Sol-Gel Technologies (SLGL) CFO details share and option holdings - Stock Titan
Director Gottfried Ran details Sol-Gel Technologies (SLGL) share and option holdings - Stock Titan
Sol-Gel Technologies (SLGL) director lists 7,500 stock options at $12 - Stock Titan
Sol-Gel Technologies (SLGL) director reports 7,500-share stock option holding - Stock Titan
Sol-Gel (SLGL) director discloses fully vested 2,031 share option - Stock Titan
Sol-Gel Technologies (SLGL) director files initial insider Form 3 - Stock Titan
Sol-Gel Technologies (SLGL) CBO Michael Glezin reports shares and stock options - Stock Titan
[Form 3] Sol-Gel Technologies Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Sol-Gel Technologies (SLGL) VP discloses shares and option grants - Stock Titan
Weekly Recap: Can Sol Gel Technologies Ltd beat the S P 500Quarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update - MarketBeat
Trade Report: Can Sol Gel Technologies Ltd maintain its current growth rate2026 Analyst Calls & Fast Exit Strategy with Risk Control - baoquankhu1.vn
This Under-the-Radar Stock Has Surged 1,300% Over the Past Year - inkl
SLGL (NASDAQ) Form 144: Insider sales reported by Yosef Itzik - Stock Titan
SLGL Earnings History & Surprises | EPS & Revenue Results | SOL-GEL TECHNOLOGIES LTD (NASDAQ:SLGL) - ChartMill
SLGL SEC FilingsSol Gel Technolg 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sol Gel Technologies Ltd (SLGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):